Quantora — Markets, Analysis & Valuation

Valuations are estimates only, produced by transparent models for education and research. This is not financial advice. Verify before trading.

Merck & Co Inc — Valuation Dashboard

Download PDF report Company page

MARKET PRICE

115.44

DCF (FCFF)

-40.86

-135.39% vs market

COMPARABLES

n/a

DIVIDEND (DDM)

n/a

ASSET-BASED

n/a

QUALITY SCORE

…

Implied values per model vs market — models disagree by design; each makes different assumptions. Estimates only.

Composite signal

Watch

Health Care · sig-v0.1 · confidence 20/100

Value

Quality

Momentum

Low-vol

Composite 71 (93th percentile in Health Care)

MOS

Value

Band

Trend

The model flags: MOS 381.9% vs 50% needed [pass] · relative value [pass] · composite 93 pct, band in [pass] · trend confirmed [pass]. Confidence 20/100.

Educational model classification — not a buy/sell recommendation, and not personalised. Verify before trading.

As of 2026-06-17 06:00 UTC.

Assumptions

Year-1 revenue growth %

Terminal growth %

Target operating margin %

Tax rate %

WACC override % (blank = CAPM)

Defaults derive from the company's statements; risk-free rate source: FRED:DGS10 (4.43 %). Any change is recorded as a user override in the audit trail.

Inputs from statements

Revenue (latest FY)	65.01B
Operating margin	0.0 %
Net debt	32.19B
Diluted shares	2.51B
Beta	1.00 (default)
Market price	115.44

Fundamentals as of 2025-12-31 · Source: DEMO

INTRINSIC VALUE / SHARE

-40.86

MARKET PRICE

115.44

UPSIDE

-135.39%

MARGIN OF SAFETY

382.6 %

Enterprise value -70.24B · Equity value -102.43B · WACC 8.66 % · Formula v1.0 · Audit run 9ba8e71a

No beta available — defaulting to 1.0.

Base-year free cash flow is negative — DCF is unreliable for cash-burning businesses.

Bull/base/bear scenarios, sensitivity tables and the comparable / dividend / asset-based models require the Pro tier — the DCF summary above is included in Free. (Billing integration pending; tiers live in the subscriptions table.)